43

Med Fasciolaosis

Embed Size (px)

DESCRIPTION

Medical college lectures: Medical helminths 3nd year.

Citation preview

Page 1: Med Fasciolaosis
Page 2: Med Fasciolaosis

EtiologyEtiologyGlobal zoonotic diseaseGlobal zoonotic disease

Page 3: Med Fasciolaosis

DISEASES CAUSED BY FLUKES IN THE BILE DUCT

 ClonorchiasisOpisthorchiasisFascioliasis

ParasiteClonorchis sinensisOpisthorchis felineusFasciola hepatica

Other mammalian hosts

Dogs, cats, pigsDogs, cats, foxes, pigsSheep, cattle

Mode of spread

Ova in faeces, waterAs for C. sinensisOva in faeces on to wet pasture

1st intermed host

SnailsSnailsSnails

2nd intermed host

Freshwater fishFreshwater fishEncysts on vegetation

Geographical distribution

Far East, especially South China

Far East, especially North-east Thailand

Cosmopolitan, including UK

PathologyE. coli cholangitis, abscesses, biliary carcinoma

As for C. sinensisToxaemia, cholangitis, eosinophilia

SymptomsOften symptom-free, recurrent jaundice

As for C. sinensisUnexplained fever, tender liver, may be ectopic, e.g. subcutaneous fluke

DiagnosisOva in stool or duodenal aspirate

As for C. sinensisAs for C. sinensis, also serology

PreventionCook fishCook fishAvoid contaminated watercress

TreatmentPraziquantel 25 mg/kg 8-hourly for 2 days

As for C. sinensis but for 1 day only

Triclabendazole 10 mg/kg single dose; repeat treatment may be required

Page 4: Med Fasciolaosis

Most of the areas with high endemicity of human fascioliasis Most of the areas with high endemicity of human fascioliasis involve involve F.hepaticaF.hepatica..

In Africa In Africa F. giganticaF. gigantica predominates. predominates.

In Asia / Egypt: In Asia / Egypt: F. hepaticaF. hepatica / / F. giganticaF. gigantica overlapsoverlaps & difficult to & difficult to identify the particular species involved, so referred to as identify the particular species involved, so referred to as Fasciola Fasciola speciesspecies

Page 5: Med Fasciolaosis

Infective stageInfective stage

ExcystationExcystation

Migration Migration

Diagnostic stageDiagnostic stage

Page 6: Med Fasciolaosis

Epidemiological conceptClinical concept

Page 7: Med Fasciolaosis

• Fasciola species inhabit the hepatobiliary system causing

considerable human morbidity dependent on the number of worms & stage of infection

Page 8: Med Fasciolaosis

• The course of infection passes through three phases: • The acute phase • The chronic phase • The obstructive phase

• Pathology / clinical manifestations are related to the phase

Page 9: Med Fasciolaosis

The acute phase:The acute phase: Coincides with migration Coincides with migration

of the of the immature flukesimmature flukes through the peritoneal through the peritoneal cavity, penetrating liver cavity, penetrating liver capsule then throughcapsule then through

liver parenchymaliver parenchyma till they till they reach the bile ducts. reach the bile ducts.

liverliver

Page 10: Med Fasciolaosis

It persists for several weeks It persists for several weeks to months (3-4 months)to months (3-4 months)

Severe pathology results Severe pathology results from parasite migration from parasite migration / / destructiondestruction of parenchymal tissue, of parenchymal tissue, causingcausing

toxic and allergictoxic and allergic reactions reactions

adultadult

liverliver

Page 11: Med Fasciolaosis

Symptoms Symptoms ::

Acute symptomsAcute symptoms Asymptomatic (Asymptomatic (unusualunusual)) Severe illnessSevere illness (prostration & jaundice) (prostration & jaundice) ((unusualunusual))

• Acute dyspepsia

• Prolonged high fever

• Hepatomegaly/ abdominal pain in the right hypochondrium

•Urticaria

•Peripheral eosinophilia, up to 80%.

•Anaemia

Page 12: Med Fasciolaosis

The The chronicchronic phase, phase, coincides with the coincides with the presence of the presence of the flukesflukes in the in the bile ductsbile ducts

The life span of the The life span of the parasite is 10-13 parasite is 10-13 yearsyears

Pathology tends to be Pathology tends to be mildmild

Page 13: Med Fasciolaosis

Symptoms : • Asymptomatic

Few gastrointestinal symptoms• Intermittent fever with persistent

prominent eosinophilia Recurrences of the acute signs & symptoms

Recurrent cholangitis

Page 14: Med Fasciolaosis

Obstructive phaseObstructive phase (heavy / prolonged (heavy / prolonged

infection) infection) Coincides with epithelial Coincides with epithelial

changes in the changes in the bile ductsbile ducts due to irritation of the due to irritation of the epithelium epithelium

by the by the spinesspines& the activity of & the activity of prolineproline

Page 15: Med Fasciolaosis

Severe pathology Severe pathology occur occur in the form of epithelial in the form of epithelial hyperplasia & proliferation, hyperplasia & proliferation, periductal periductal inflammationinflammation

then then fibrosis fibrosis &even &even calcification leading to calcification leading to partial obstructionpartial obstruction

SymptomsSymptoms Recurrent cholangitis & Recurrent cholangitis &

cholecystitis (calculous or cholecystitis (calculous or acalculous)acalculous)

adultsadults

Page 16: Med Fasciolaosis

Ectopic fascioliasisEctopic fascioliasis may occur during any of the three phases of may occur during any of the three phases of the disease but is most common during the acute phasethe disease but is most common during the acute phase

11.. Juveniles that migrate out of the intestine but Juveniles that migrate out of the intestine but do not locate in do not locate in the liverthe liver so they form ectopic lesions in many abdominal so they form ectopic lesions in many abdominal tissuestissues

22..Juveniles that enter the Juveniles that enter the portal circulationportal circulation, so distributed , so distributed throughout the bodythroughout the body. .

Manifested as masses, abscesses, migration tracks or Manifested as masses, abscesses, migration tracks or haemorrage.haemorrage.

These are often These are often misdiagnosedmisdiagnosed as malignant ulcers or as malignant ulcers or tumours . tumours .

Exploratory abdominal surgery may be needed to make the Exploratory abdominal surgery may be needed to make the diagnosisdiagnosis

Page 17: Med Fasciolaosis

Interesting ectopic sites & lesionsInteresting ectopic sites & lesions Gastric fascioliasisGastric fascioliasis Fascioliasis of the head of pancreasFascioliasis of the head of pancreas A mass in the right iliac fossa A mass in the right iliac fossa The peritoneal cavity massive ascitis The peritoneal cavity massive ascitis Mitral insufficiency secondary to myocardial fibrosis Mitral insufficiency secondary to myocardial fibrosis intraocular bleeding intraocular bleeding Hydrocele due to epididymitisHydrocele due to epididymitis Effusion of the knee joint Effusion of the knee joint Ectopic Ectopic FasciolaFasciola worms in the ankle joint worms in the ankle joint Cervical / generalized lymphadenopathy Cervical / generalized lymphadenopathy Abdominal subcutaneous nodules Abdominal subcutaneous nodules Pleural effusion associated with/without pulmonary Pleural effusion associated with/without pulmonary

infiltrates, pyopneumothorax & pleurisy .infiltrates, pyopneumothorax & pleurisy .

Page 18: Med Fasciolaosis

1. Liver abscess & haematoma (subcapsular) (acute stage)2. Biliary cirrhosis :due to the peri-ductal fibrosis 3. Obstructive jaundice : Obstruction of the common bile duct by

Fasciola adults +.4. Biliary sludge / stones: in gall bladder & biliary tree may be

formed in chronic patients, which remains unchanged after therapy may predispose to recurrent cholecystitis, cholangitis or biliary stone

5. Bleeding : Bleeding may occur due to ulcerations in the common bile duct (haemobilia)

6. Death: rare, major causes of death are biliary bleeding & biliary cirrhosis

Page 19: Med Fasciolaosis

DiagnosisDiagnosis 1.1. Clinical Clinical + + the the

haematological /biochemical haematological /biochemical findingsfindings

22.. Parasitological diagnosisParasitological diagnosis 33.. Immuno-diagnosisImmuno-diagnosis 44.. Imaging proceduresImaging procedures 5. Liver biopsy5. Liver biopsy

1

2 3

4 5

Page 20: Med Fasciolaosis

Clinical + the haematological / biochemicalNot reliable because:

• The clinical manifestations are not markedly different from hepatobiliary disease of other origins.

so hepatomegaly, fever, anaemia , marked eosinophilia are only highly suggestive of the disease

• Ectopic localization of the parasite may cause a confusing clinical presentation

Page 21: Med Fasciolaosis

2. Parasitological diagnosis:- Eggs are not excreted during the

invasive stage of infection when many patients present with severe symptoms

- Sometimes eggs are undetectable during the chronic phase.

- Differentiation of eggs of F. hepatica, F. gigantica, echinostomes & Fasciolopsis is difficult

Page 22: Med Fasciolaosis

3. Immunodiagnosis: The advantage over parasitological techniques is:

Can detect early, prepatent infections as well as chronic stage with little or no egg output.

Tests have been developed for• Detection of Fasciola antigens (Circulating, Coproantigens) • Detection of the circulating antibodies (IgM, IgG, IgG4)• Detection of the circulating immune complexes.

Page 23: Med Fasciolaosis

Sources of antigens1. Adult (crude,purified…. Whole somatic extract of adult Tegumental extract of the

surface tegument Excretory-secretory products

(ES) contain several enzymes such as cysteine proteinase and cathepsin- L proteinases.

2. Metacercarial antigen and juvenile somatic antigen

3. Miracidial antigen

Page 24: Med Fasciolaosis

Numerous assays for immunodiagnosis:• ELISA• Indirect haemagglutination test (IHA)• Counter immuno electrophoresis (CIEP)• Indirect fluorescent antibody test (IFA)Problems with cross-reactivity with other trematode infections are

avoided by using purified specific antigens, or specific antibody subclasses (IgG4)

Many techniques revealed 100% sensitivity & specificity e.g. IgG4 ELISA (recombinant CL-1) & cystatin capture ELISA (cysteine proteinase)

Page 25: Med Fasciolaosis

4. Imaging Various imaging techniques proved useful to diagnose human

fascioliasis 1. Ultrasonography (US) 2. Computed Axial Tomography(CAT) 3. Magnetic Resonance Imaging (MRI) 4. Endoscopic Retrograde Cholangio-Pancreatography

(E.R.C.P.) 5. Percutaneous transhepatic cholangiographv (P.T.C)

Page 26: Med Fasciolaosis

Valuable in the diagnosis of… The migratory tracks of the juvenile flukes

seen as peripherally located branching or tortuous lesions

Pathological lesions secondary to migration e.g. abscesses & parenchymal hemorrhages

CTCT

Page 27: Med Fasciolaosis

Vermiform flukes moving within the gall bladder

sonarsonar

Page 28: Med Fasciolaosis

Hepatomegaly & periportal fibrosis

Bile aspiration from the gall bladder for verification in cases suspicious to be metastatic liver disease (US, E.R.C.P)

Page 29: Med Fasciolaosis

5. Liver biopsy may demonstrate:

• Microabscesses • Tunnels of parenchymal necrosis• Eggs & adult worms

adultadult

liverliver

Page 30: Med Fasciolaosis

Curative treatment is essential in human fascioliasis to control symptoms & to avoid the hepatobiliary complications

• Several drugs have been used& efficacy was often variable

Page 31: Med Fasciolaosis

• Chemotherapeutic agents in common use in human fascioliasis: Effective with no or little side effects: Triclabendazole, bithionol,

Mirazid Effective with side effects: severe (dehydroementine), or

moderate (Metronidazole) Controversial therapeutic results (Praziquantel)

Page 32: Med Fasciolaosis

Triclabendazole TCZ appears to be the drug of choice for acute & chronic human fascioliasis, recently registered for human use

against fascioliasis (WHO, 1998): Effective against juveniles / adults

Excellent tolerance &efficacy in adults &children Ease of administration (single oral dose)

Several reports documented its efficacy in the treatment of the disease since 1988.

Page 33: Med Fasciolaosis

The criteria for cure :1) Amelioration of symptoms & achievement of clinical

wellbeing (Clinical cure) 2) Normalization of haematological & biochemical data:

declining then returning to normal values 3) Absence of ova (parasitologic cure) in repeated stool

examinations in chronic cases 4) Decreasing antigenaemia / antibody levels 5) Disappearance or improvement of imaging findings

Page 34: Med Fasciolaosis

Treatment efficacyTreatment efficacy • The detection of circulating Fasciola antigen & coproantigen is an

efficient immuno-diagnostic tool to assess the effect of therapy in fascioliasis, as antigenaemia in the host reflects an active infection

• Role of antibody detection to assess treatment efficacy is controversial.

Some claim that none of the Fasciola isotypes change after treatment, even after 6 months,

others documented the drop of antibodies rapidly after successful treatment

Page 35: Med Fasciolaosis

• Individuals who do not respond to oral drug therapy can be treated successfully by biliary drainage & the take out of worms or by flushing of the biliary system with povidone iodide

Page 36: Med Fasciolaosis

The epidemiological picture of the disease has changed in recent years.

Page 37: Med Fasciolaosis

• The expected correlation between animal & human fascioliasis was found to occur only at a basic level.

• A high prevalence in humans does not seem to correlate with areas where fascioliasis is a major veterinary problem

Page 38: Med Fasciolaosis

Prevalence /distribution

The number of humans infected with Fasciola species has increased significantly since 1980 & several geographical areas have been described as endemic for the disease in humans, with prevalence & intensity ranging from low to very high.

Reports from Turkey & Iran.

Page 39: Med Fasciolaosis

• The disease is worldwide in distribution but endemic in South & Central America, Puerto Rico, the Caribbean region, many parts of Africa, Asia, the Middle East, Australia, China.

• There have been a number of focal outbreaks reported from Europe, including southern France & the Mediterranean region

Page 40: Med Fasciolaosis

There is a significant positive association between human fascioliasis & schistosomiasis mansoni

Page 41: Med Fasciolaosis

Snail intermediate host

Page 42: Med Fasciolaosis

Reservoir hosts

Page 43: Med Fasciolaosis

1. Periodic examination / treatment of livestock

2. Control of the snail vectors 3. Health education. 4. People must be aware of how

infection might occur.